Theravance Biopharma, Inc. · NASDAQ:TBPH

Madison Avenue Partners, LP reported a 17.70% stake in Theravance Biopharma, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Madison Avenue Partners, LP reported a 17.70% stake in Theravance Biopharma, Inc., 9,212,252 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
17.70%
Shares
9,212,252
Intent
Passive
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Madison Avenue International LP17.70%9,212,252
Madison Avenue Partners, LP17.70%9,212,252
EMAI Management, LLC17.70%9,212,252
Madison Avenue GP, LLC17.70%9,212,252
Caraway Jackson Investments LLC17.70%9,212,252
Eli Samaha17.70%9,212,252

Source

View original at SEC

Related